JP2013078552A - System, method and program for examining brain function - Google Patents

System, method and program for examining brain function Download PDF

Info

Publication number
JP2013078552A
JP2013078552A JP2011232244A JP2011232244A JP2013078552A JP 2013078552 A JP2013078552 A JP 2013078552A JP 2011232244 A JP2011232244 A JP 2011232244A JP 2011232244 A JP2011232244 A JP 2011232244A JP 2013078552 A JP2013078552 A JP 2013078552A
Authority
JP
Japan
Prior art keywords
value
dementia
brain function
healthy
pegs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011232244A
Other languages
Japanese (ja)
Inventor
Akio Tsuboi
章雄 坪井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ibaraki Prefecture
Original Assignee
Ibaraki Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ibaraki Prefecture filed Critical Ibaraki Prefecture
Priority to JP2011232244A priority Critical patent/JP2013078552A/en
Publication of JP2013078552A publication Critical patent/JP2013078552A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medical Treatment And Welfare Office Work (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method and an apparatus for examining a brain function, which enable dementia and the degree of aging of the brain function to be more accurately determined by examining a delicate finger motion function of handedness.SOLUTION: In this system, selection is performed between the case of the first performance of an examination and the case of the second or subsequent performance of the examination by a subject selecting means 101. In the case of the first performance, subject information is input by a subject information input means 102. Both a new examiner and a second or subsequent examiner are subjected to the examination by a new measurement data input means 103. Additionally, comparison of them with an able-bodied person's ability is performed by a calculation means 106, and the results of the comparison are stored in memory 107.

Description

本発明は、一般に、中枢神経系(CNS)の発達起源の評価ではなく、高齢者におけるCNSの加齢および認知症により誘発された認知機能障害の評価のためのシステムおよび方法の分野に関する。より詳細には、本発明は、人が、認知症により誘発された認知機能障害に苦しみ、またはその危険にさらされているかどうかを手指巧緻動作(Fingers Dexterity)で分析することによって、脳機能の老化度や認知症に対するリスクを年代毎に%で示すためのシステムおよび方法に関する。  The present invention relates generally to the field of systems and methods for assessment of CNS aging and cognitive impairment induced by dementia in the elderly, rather than assessment of the developmental origin of the central nervous system (CNS). More particularly, the present invention analyzes brain function by analyzing whether a person suffers from or is at risk of cognitive dysfunction induced by dementia. The present invention relates to a system and method for indicating the degree of aging and the risk for dementia in% by age.

脳は、加齢するCNSによって多くの様々な様式で損傷する可能性があり、CNSの変化は、そのような何十年にもわたる変化の臨床的根拠に先行し得るものである。CNSの変化は、たとえば、軽度認知機能障害(MCI)、小さなまたは大きな血管の疾患、血液脳関門の損傷、アテローム硬化症などで確認することができ、進行中の脳損傷過程の臨床症候は、そのような過程の進展の特定の点に達するまで明らかにならない可能性がある。  The brain can be damaged in many different ways by an aging CNS, and changes in the CNS can precede the clinical basis of such decades-long changes. Changes in the CNS can be confirmed, for example, in mild cognitive impairment (MCI), small or large vascular disease, blood brain barrier damage, atherosclerosis, etc. Clinical symptoms of the ongoing brain damage process are It may not be apparent until a certain point in the progress of such a process is reached.

そのような過程が加速し、臨床的に明らかになった疾患には、たとえば、認知症、アルツハイマー病(AD)、などが挙げられるが、その他の多くのCNS疾患も含まれる。  Diseases that have accelerated such processes and have become clinically apparent include, for example, dementia, Alzheimer's disease (AD), and many other CNS diseases.

多くの人が、そのような疾患に冒されている。認知症および認知症に関連する疾患は、実際に、心臓病、癌、および脳卒中についで、全世界のうちの先進工業国で多い死因の4位になっている。人口が12700万人の日本のみでも、人口の1.9%にあたる約240万人が認知症に苦しんでいる。全人口に対する高齢者の割合は、平均寿命が延びるために増加し、厚生労働省の統計では、2002年に154万人、2005年に238万人、2010年に320万人となり、2020年に446万人、2030年に545万人と時間とともに急激に増加が予測されている。したがって、適切な治療を提供できるようにするために、認知症を進展させる危険にさらされている人、または特定の度合いの認知症を有する人をできるだけ早く識別する必要がある。  Many people are affected by such diseases. Dementia and diseases related to dementia are actually the fourth leading cause of death in industrialized countries worldwide, following heart disease, cancer, and stroke. Even in Japan, which has a population of 127 million people, about 2.4 million people, or 1.9% of the population, suffer from dementia. The ratio of elderly people to the total population has increased due to the extension of life expectancy. According to statistics from the Ministry of Health, Labor and Welfare, the number of the elderly is 1,540,000 in 2002, 2.38 million in 2005, 3.2 million in 2010, and 446 in 2020. The number is expected to increase rapidly over time, reaching 5.45 million in 2030. Therefore, in order to be able to provide adequate treatment, it is necessary to identify as soon as possible those who are at risk of developing dementia or who have a certain degree of dementia.

従来、認知症の確定診断手法は確立されておらず、様々な検査結果を考慮して総合的に診断を行っている。認知症の補助的評価法として画像診断がある。コンピューター断層撮影(CTスキャン)およびMRI(磁気共鳴画像装置)は、今日広く脳疾患の臨床評価に用いられている。また、SPECT(単一光子放射型断層撮影)が日常の臨床検査場面で使用され、NIRS(光トポグラフィ)やPET(機能的MRI)などの他の技術が、脳血流、脳代謝過程、および神経伝達物質の機能を評価する検査目的に使用されている。  Conventionally, a definitive diagnosis method for dementia has not been established, and comprehensive diagnosis is performed in consideration of various test results. Image diagnosis is an auxiliary evaluation method for dementia. Computed tomography (CT scan) and MRI (Magnetic Resonance Imaging) are widely used today for clinical evaluation of brain diseases. In addition, SPECT (single photon emission tomography) is used in daily clinical examination scenes, and other techniques such as NIRS (optical topography) and PET (functional MRI) are used for cerebral blood flow, cerebral metabolic processes, and It is used for testing purposes to evaluate the function of neurotransmitters.

認知症の検査方法の一つには、被験者に対して問診や問答を行う神経心理学検査があり、特別な検査器具が不要で簡単に行えるため、広く用いられている。例えば日本語による神経心理学検査としては改訂長谷川式知能評価スケール(HDS−R)、国立精研式痴呆スクリーニングテスト、N式精神機能検査、かなひろいテスト、ミニメンタルステイトエグザミネイション(MMSE)などの知能評価方法があり、英語によるものではMMSE(mini mental state examination)やADAS(Alzheimer’s Disease Assessment Scale Cognitive Subscale)などがある。また、行動評価を加味したCDR(Clinical Dementia Rating)などを用いることによって、認知症の有無やその重症度の診断を行うこともできる。  One of the methods for testing for dementia is a neuropsychological test in which a subject is asked and answered, and is widely used because it does not require a special test tool and can be easily performed. For example, Japanese neuropsychological tests include the revised Hasegawa Intelligence Assessment Scale (HDS-R), the National Seken Type Dementia Screening Test, the N-type Psychiatric Function Test, the Kana Hiroi Test, and the Mini Mental State Examination (MMSE). Intelligent evaluation methods such as MMSE (minimum state examination) and ADAS (Alzheimer's Disease Assessment Coordinate Subscale) are available. In addition, the presence or absence of dementia and the severity thereof can be diagnosed by using CDR (Clinical Dimension Rating) and the like in consideration of behavioral evaluation.

また、人間の瞳孔対光反応や発語、触覚等を利用して認知検査を実施する自動化システムが開発されてきた。たとえば特開2002−034920号公報または特表2011−502564号公報に開示されている。特開2002−034920号公報では、被験者の瞳孔対光反応により脳機能の老化度合いや、自律神経系疾患や痴呆症さらにアルツハイマー病などの脳疾患の検査ができるような脳機能検査装置が開示されている。また、特表2011−502564号公報では、人の発語(speech)を分析することによって脳機能障害の発生および脳機能障害の段階を診断するための脳機能検査装置が開示されている。そのほかに、触覚による診断方法(非特許文献1)も開発されている。  In addition, automated systems have been developed that perform cognitive tests using human pupillary light response, speech, touch, and the like. For example, it is disclosed by Unexamined-Japanese-Patent No. 2002-034920 or Japanese translations of PCT publication No. 2011-502564. Japanese Patent Application Laid-Open No. 2002-034920 discloses a brain function test apparatus that can test the degree of aging of brain function, brain disease such as autonomic nervous system disease, dementia, and Alzheimer's disease by subject's pupillary light reaction. ing. In Japanese translations of PCT publication No. 2011-502564, a brain function testing device for diagnosing the occurrence of brain dysfunction and the stage of cerebral dysfunction by analyzing a person's speech is disclosed. In addition, a tactile diagnostic method (Non-Patent Document 1) has been developed.

特開2002−034920号公報JP 2002-034920 A 特表2011−502564号公報Special table 2011-502564 gazette

Jiajia Yang,Takashi Ogasa,Yasuyuki Ohta,Koji Abe,Jinglong Wu:Decline of Human Tactile Angle Discrimination in patients with Mild Cognitive Impairment and Alzheimer’s Disease,Journal of Alzheimer’s Disease 22(1):225−34,2010.Jiajia Yang, Takashi Ogasa, Yasuyuki Ohta, Koji Abe, Jinglong Wu: Decline of Human Tactile Angle Discrimination in patients with Mild Cognitive Impairment and Alzheimer's Disease, Journal of Alzheimer's Disease 22 (1): 225-34,2010.

CTやMRI、SPECTなどの画像診断は、検査を行うのに高額な検査機器や医療従事者が必要であることや、実施時間が長いことや、病気以外では検査費用が高額になることなど多くの問題を抱えている。  Image diagnosis such as CT, MRI, SPECT, etc. requires expensive inspection equipment and medical staff to perform the inspection, it takes a long time, and inspection costs are high except for diseases. Have problems.

また、神経心理学検査は簡単に行えるため、多大な費用と時間を要する精密検査の前に行うスクリーニング検査に向いており、また医療従事者以外の検査者でも行えるという利点がある。しかしながら、上述した神経心理学検査では、被験者の協力が不可欠であり、その取り組み方によって検査結果が左右される虞があり、また検査者の被験者に対する質問の仕方によって検査結果が変わることもあり、主観的な検査方法であることに起因して検査結果に偏りが生じる虞もある。  In addition, since the neuropsychological test can be easily performed, it is suitable for a screening test performed before a detailed test that requires a large amount of money and time, and there is an advantage that it can be performed by an examiner other than a medical worker. However, in the above-mentioned neuropsychological examination, the cooperation of the subject is indispensable, the examination result may be affected by the approach, and the examination result may change depending on how the examiner asks the question, There is also a possibility that the inspection results may be biased due to the subjective inspection method.

従来より、アルツハイマー型認知症患者と健常者との間で、非侵襲的計測が可能な対象である利き手巧緻動作運動などで有意差があることが研究論文などで報告されており、この有意差を利用して従来診断が困難であったアルツハイマー型認知症の検査が行えることも示唆されている。また、加齢と巧緻動作に関する研究は、今までにも多く行われ、巧緻動作能力は幼児より成長に伴い発達し、老化に伴い低下するという変化が知られている。  Research papers have reported that there is a significant difference between Alzheimer-type dementia patients and healthy individuals in dominant hand-skilled movements that are noninvasive measurement targets. It has also been suggested that Alzheimer's type dementia, which has been difficult to diagnose using conventional methods, can be tested. Further, many studies on aging and skillful movements have been conducted so far, and it is known that skillful movement ability develops with growth and decreases with age.

しかしながら、従来の巧緻動作検査では、各年齢別の巧緻動作の指標が示されておらず、そのまま使用して検査を行う場合は、検査の精度に制限があると予想される、認知症の判定、更には脳機能の老化度合いを判定するのは難しいと考えられる。  However, in the conventional sophisticated motion test, the index of sophisticated motion for each age is not shown, and if it is used as it is, the accuracy of the test is expected to be limited. Furthermore, it is considered difficult to determine the degree of aging of brain function.

本発明は上記問題点に鑑みて為されたものであり、その目的とするところは、簡単な方法で精度良く脳機能の検査を行える脳機能検査方法とその装置、脳機能検査システム、脳機能検査サービス方法及びそのプログラムと装置を提供することにある。  The present invention has been made in view of the above problems, and its object is to provide a brain function test method and apparatus, brain function test system, and brain function that can accurately test brain function with a simple method. It is to provide an inspection service method and a program and apparatus thereof.

本発明は、特許第4431729「手指の巧緻動作能力を検査するシステム、方法及びプログラム」の6つのサブテストうち、中ペグの返し動作を用いた被検者の脳機能を検査するシステムであって、両端部の色が異なる9本のペグと、当該ペグが着脱可能であって、縦に3個ずつ3列に9個の孔が縦横等間隔に配列するボードとを用い、当該ボードの片側3列に差し込まれたペグを、利き手のみの操作で1本ずつ抜いたのち、上下を逆にして差し込む返し動作の時間を計測し、計測値を入力する計測値入力手段と、前記計測値と、予め健常者を対象に求めた健常者基準値および、同年代の認知症者を対象として求めた認知症者基準値とを基に、年代毎の認知症のリスクを示す脳機能を算出する能力算出手段を備えることを特徴とする。  The present invention is a system for inspecting the brain function of a subject using the return motion of the middle peg among the six subtests of the patent No. 4431729 “system, method and program for inspecting skillful movement ability of fingers”. One side of the board using nine pegs having different colors at both ends and a board in which the pegs are detachable and three holes are arranged in 3 rows and 9 holes are arranged at equal intervals vertically and horizontally The pegs inserted in the three rows are pulled out one by one by the operation of only the dominant hand, and then the time for the return operation to be inserted upside down is measured, and the measured value input means for inputting the measured value; Ability to calculate brain function that indicates the risk of dementia by age, based on the standard values for healthy people previously determined for healthy individuals and the standard values for people with dementia of the same age A calculating means is provided.

また、被検者の認知症に対するリスクを示す脳機能を検査するシステムであって、前記計測値が2回の同じ動作の時間の平均値であることを特徴とする。  Moreover, it is a system which test | inspects the brain function which shows a subject's risk with respect to dementia, Comprising: The said measured value is an average value of the time of two same movements, It is characterized by the above-mentioned.

また、コンピュータを用いて構築された被検者の認知症に対するリスクを示す脳機能を検査する方法であって、前記コンピュータが備える計測値入力手段が、両端部の色が異なる9本のペグと、当該ペグが着脱可能であって、縦に3個ずつ3列に9個の孔が縦横等間隔に配列するボードとを用い、当該ボードの片側3列に差し込まれたペグを、利き手のみの操作で1本ずつ抜いたのち、上下を逆にして差し込む返し動作の時間を計測し、計測値を入力するステップと、次いで、前記コンピュータが備える能力算出手段が、前記計測値と、予め健常者を対象に求めた健常者基準値および、同年代の認知症者を対象として求めた認知症者基準値とを基に、年代毎の認知症のリスクを示す脳機能を算出するステップを実行することを特徴とする。  Further, it is a method for examining a brain function indicating a risk of dementia of a subject constructed using a computer, and the measurement value input means provided in the computer includes nine pegs having different colors at both ends. The pegs are detachable, and the pegs inserted in three rows on one side of the board are used only by the dominant hand using a board in which nine holes are arranged in three rows and three holes in a row and are arranged at equal intervals vertically and horizontally. After pulling out one by one, measuring the time of the return operation to insert upside down, inputting the measured value, and then the ability calculation means provided in the computer, the previously measured value and the healthy person To calculate the brain function indicating the risk of dementia for each age group based on the standard value for healthy persons determined for patients and the standard value for persons with dementia of the same age It is characterized by.

また、被検者の認知症に対するリスクを示す脳機能を検査する方法であって、両端部の色が異なる9本のペグと、当該ペグが着脱可能であって、縦に3個ずつ3列に9個の孔が縦横等間隔に配列するボードとを用い、1本ずつ抜いたのち、上下を逆にして差し込む返し動作の時間を計測し、計測値を求める工程と、次いで、前記計測値と、予め健常者を対象に求めた健常者基準値および、同年代の認知症者を対象として求めた認知症者基準値とを基に、年代毎の認知症のリスクを示す脳機能を算出する工程を含むことを特徴とする。  In addition, a method for examining a brain function indicating a risk of dementia of a subject, wherein nine pegs having different colors at both ends and the pegs are detachable, each having three columns in three rows Using a board in which nine holes are arranged at equal intervals in the vertical and horizontal directions, and after pulling out one by one, measuring the return operation time by inserting it upside down, obtaining the measured value, and then measuring the measured value And the brain function indicating the risk of dementia by age based on the healthy person reference value obtained in advance for healthy persons and the dementia person reference value obtained for persons with dementia of the same age Including a process.

また、コンピュータを、被検者の認知症に対するリスクを示す認知機能を検査する手段として機能させるためのプログラムであって、前記コンピュータを、両端部の色が異なる9本のペグと、当該ペグが着脱可能であって、縦に3個ずつ3列に9個の孔が縦横等間隔に配列するボードとを用い、当該ボードの片側3列に差し込まれたペグを、1本ずつ抜いたのち、上下を逆にして差し込む返し動作の時間を計測し、計測値を入力する計測値入力手段として機能させ、次いで、前記コンピュータを、前記計測値と、予め健常者を対象に求めた健常者基準値および、同年代の認知症者を対象として求めた認知症者基準値とを基に、年代毎の認知症のリスクを示す脳機能を算出する能力算出手段として機能させることを特徴とする。  Further, a program for causing a computer to function as a means for examining a cognitive function indicating a risk of dementia of a subject, the computer comprising nine pegs having different colors at both ends and the peg Using a board that is detachable and has 3 holes vertically arranged in 3 rows and 9 holes arranged at equal intervals vertically and horizontally, after removing the pegs inserted in 3 rows on one side of the board one by one, Measure the time of the return operation to insert upside down, let it function as a measurement value input means for inputting the measurement value, then the computer, the measurement value and a healthy person reference value obtained in advance for a healthy person And based on the dementia reference value calculated | required targeting at the dementia person of the same age, it is made to function as an ability calculation means to calculate the brain function which shows the risk of dementia for every age.

このように構成した本発明によれば、被検者の利き手の手指巧緻動作能力を測定することで、脳機能を検査するシステムであり、予め健常者を対象に求めた健常者基準値および、同年代の認知症者を対象として求めた認知症者基準値とを基に、年代毎の認知症のリスクを示す脳機能を算出するために、加齢による脳機能の低下も加味したより正確な結果を示すことが可能になる。このシステムでは、検査者を必要とせず、画面に示された指示に基づいて検査を行うことで、検査結果が自動的に表示され、結果に基づく内容の説明が自動的に行われる。  According to the present invention configured as described above, it is a system for inspecting brain function by measuring the hand skillful movement ability of the dominant hand of the subject, and a healthy person reference value obtained in advance for a healthy person, and In order to calculate the brain function that shows the risk of dementia by age group based on the dementia standard value obtained for people with dementia of the same age, more accurate considering the decrease in brain function due to aging It becomes possible to show the result. In this system, an inspector is not required, and the inspection result is automatically displayed by performing the inspection based on the instruction shown on the screen, and the contents based on the result are automatically explained.

また、失語症などの言語障害がある場合、HDS−Rなどの質問紙による認知機能検査は困難となる。しかし、巧緻動作運動などの動作性検査では言語障害などの有する対象者に対しても検査が可能となる。また、質問紙による検査は、医療従事者による検査者が必要になるが、本発明では必ずしも医療従事者が検査を行う必要はなく、早期発見のため被験者自身が検査するセルフケアへの応用も期待される。  In addition, when there is a language disorder such as aphasia, it is difficult to perform a cognitive function test using a questionnaire such as HDS-R. However, operability tests such as skillful movements can be performed even on subjects who have language problems. In addition, the examination by the questionnaire requires an inspector by a medical staff, but in the present invention, the medical staff does not necessarily need to perform the examination, and it is expected to be applied to self-care that is examined by the subject himself for early detection. Is done.

また、検査方法としては、9本のペグをボード上の同じ穴にひっくり返して差し込む「返し動作」を行う結果で健常者との解析が可能である。また、実施制限時間を60秒間とし、その時間内に9本のペグの「返し動作」が出来ない場合は、実施できたペグの本数で解析が可能であるために、検査時間が非常に短い。  As an inspection method, analysis with a healthy person is possible by a result of performing a “returning operation” in which nine pegs are turned over and inserted into the same hole on the board. Also, if the implementation limit time is 60 seconds and the “returning operation” of 9 pegs cannot be performed within that time, the analysis can be performed with the number of pegs that can be implemented, so the inspection time is very short. .

また、画面に表示された指示に従って年齢を入力し検査を実施すると、自動的に同年齢健常者の脳機能との比較が%で示され、年代毎の認知症のリスクを示す脳機能の結果が表示され、結果に基づく内容の説明が行われるために、検査に専門的知識を要しない。  In addition, when the age is entered according to the instructions displayed on the screen and the test is performed, a comparison with the brain function of healthy people of the same age is automatically shown in%, and the result of brain function showing the risk of dementia by age Is displayed, and the contents are explained based on the results.

以上説明したように、本発明の脳機能検査システムは検査が容易であり、失語症などの言語障害があっても検査が可能であり、簡便に持ち運びができ、検査者を必要とせず自動的に同年齢健常者の脳機能に比べ何%の能力があるかが示され、同年齢健常者の平均より低い県あの場合は年代毎の認知症のリスクを示す脳機能の結果が表示され、結果に基づく内容の説明が行われるために、認知症に対するリスクを評価・判別することができる。  As described above, the brain function testing system of the present invention is easy to test, can be tested even if there is a language disorder such as aphasia, can be easily carried, and automatically without requiring an examiner. It shows how much ability is compared with the brain function of healthy people of the same age, and in the case of the prefecture lower than the average of healthy people of the same age, the result of brain function showing the risk of dementia by age is displayed. Since the contents are explained based on the risk, the risk for dementia can be evaluated and discriminated.

本発明の基本的構成である。It is a basic configuration of the present invention. 検査初期の流れ図である。It is a flowchart at the initial stage of inspection. 検査における新規計測過程の流れ図である。It is a flowchart of the new measurement process in a test | inspection. 検査データ編集過程の流れ図である。It is a flowchart of an inspection data edit process. 検査結果表示過程の流れ図である。It is a flowchart of a test result display process. 脳機能検査システムのブロック図である。It is a block diagram of a brain function inspection system.

以下、本発明の実施の形態について図面を参照して説明する。  Hereinafter, embodiments of the present invention will be described with reference to the drawings.

図1は脳機能検査システムの基本的構成を表したものである。この脳機能検査システムは、手指の障害を持った患者の検査結果の解析・評価を自動的に行うシステムで、脳機能検査装置100から構成されている。  FIG. 1 shows a basic configuration of a brain function test system. This brain function test system is a system that automatically analyzes and evaluates test results of a patient with a hand and finger disability, and includes a brain function test apparatus 100.

対象者の脳機能を検査する脳機能検査装置100では、ペグの直径が3cm、長さが8cmの大ペグ、ペグの直径が1.5cm、長さが5cmのペグを用いる。これらのペグを差し込む脳機能検査器具には、縦に3つの穴が横3列に等間隔で並んでおり、合計9穴ある。脳機能検査器具の大きさは、縦28cm×横18cmであり、持ち運びなどの運搬しやすい大きさである。検査は、病や障害を持った対象者の身体的・心理的耐久性を配慮し、高齢者などにも理解しやすいように、9本のペグを用いて行うことで完結するように構成されている。  In the brain function testing apparatus 100 that tests the brain function of a subject, a large peg with a 3 cm diameter peg and an 8 cm length, a peg with a 1.5 cm peg diameter and a 5 cm length peg is used. The brain function test instrument into which these pegs are inserted has three vertical holes arranged at equal intervals in three horizontal rows, for a total of nine holes. The size of the brain function testing instrument is 28 cm long × 18 cm wide, and is easy to carry. The examination is designed to be completed by using nine pegs, taking into account the physical and psychological durability of subjects with illnesses and disabilities, and making it easier for elderly people to understand. ing.

脳機能検査装置100には、画面上に被検者に対して検査を行う手順を示し、被検者がそれに従って被検者情報の入力、検査測定の実施、結果の入力を行うことで情報の保存と解析・評価し、結果の評価について画面上で被検者に示すことが出来る。
[巧緻動作と認知機能の関連]
The brain function testing apparatus 100 shows a procedure for performing a test on the subject on the screen, and the subject inputs information on the subject, performs test measurement, and inputs the result according to the procedure. Storage and analysis / evaluation, and the result evaluation can be shown to the subject on the screen.
[Relationship between sophisticated movement and cognitive function]

我々が開発した特許第4431729「手指の巧緻動作能力を検査するシステム、方法及びプログラム」を用い商品化したIPUT巧緻動作検査(IPUT)を巧緻動作の指標として、多くの医療場面で用いられている改訂長谷川式簡易知能評価スケール(HDS−R)を認知機能の指標として身体的・認知的に問題なく日常生活を行っている20歳から94歳の健常者563名に対して実施した。その結果を20歳から5歳ごとの年代で区分し、被検者属性と人数および左右の手で行う6のサブテスト毎にIPUTとHDS−Rの相関を示したものである。対象とした被検者は、IPUTの6サブテストについて両手各2回ずつ計12動作を実施し作成した。  IPUT skillful motion test (IPUT), which was commercialized using our patent No. 4431729 “system, method and program for testing skillful motion ability of fingers”, is used in many medical situations as an index of skillful motion. The revised Hasegawa simplified intelligence evaluation scale (HDS-R) was used as an indicator of cognitive function for 563 healthy persons aged 20 to 94 who are physically and cognitively engaged in daily life. The results are classified by age from 20 to 5 years old, and the correlation between IPUT and HDS-R is shown for each of the 6 subtests performed by subject attributes, number of persons, and left and right hands. The subject subjects were prepared by performing a total of 12 actions for each of both hands for 6 subtests of IPUT.

Figure 2013078552
Figure 2013078552

20歳から94歳の健常者563名で、IPUTの12のサブテストとHDS−Rの間で相関係数−0.41〜−0.52と有意で高いマイナスの負の相関関係が示された(脳機能検査で用いた中ペグの返し動作では、相関係数は−0.5と高い有意な負の相関係数を示した)。また、12のサブテストとHDS−R間で大きな相関関係の違いが見られなかった。健常者においては、巧緻動作能力と認知機能との密接な負の関係が示唆された。  563 healthy people aged 20 to 94 years showed significant high negative negative correlation between 12 subtests of IPUT and HDS-R with correlation coefficient -0.41 to -0.52. (In the return movement of the medium peg used in the brain function test, the correlation coefficient showed a significant negative correlation coefficient as high as -0.5). In addition, there was no significant correlation difference between the 12 subtests and the HDS-R. In healthy individuals, a close negative relationship between skillful movement ability and cognitive function was suggested.

IPUTを巧緻動作の指標として、HDS−Rを認知機能の指標として認知症患者172名に対して実施した。認知症者は55〜100歳まで5歳ごとに分類した場合、対象者が10人以下の年代となる55〜69歳、95〜100歳の認知症者を削除した162名を対象に、70〜94歳まで5つの年代に分類しおこなった。また、利き手の影響を考え、解析に当たり左利きの対象者については、左手のデータを右手に、右手のデータを左手に補正した。その結果を対象人数が少ない55歳から69歳の他は70歳から5歳ごとの年代で区分し、被検者属性と人数および12のサブテスト毎にIPUTとHDS−Rの相関を示したものである。対象とした被検者は、IPUTの6サブテストについて両手各2回ずつ計12動作を実施し作成した。  IPUT was used as an indicator of skillful movement and HDS-R was used as an indicator of cognitive function for 172 patients with dementia. When dementia is classified every 5 years up to 55 to 100 years old, the target is 70 people who are deceased from 55 to 69 years old and 95 to 100 years old whose age is 10 or less. It was classified into five ages until ~ 94 years old. Considering the influence of the dominant hand, for left-handed subjects in the analysis, the left hand data was corrected to the right hand and the right hand data was corrected to the left hand. The results were classified according to the age of every 70 to 5 years other than the 55 to 69 years of age, which showed a correlation between IPUT and HDS-R for each subject attribute, number of people, and 12 subtests. Is. The subject subjects were prepared by performing a total of 12 actions for each of both hands for 6 subtests of IPUT.

Figure 2013078552
Figure 2013078552

認知症者に対するHDS−Rと年齢・IPUT各サブテスト相関係数は負相閧し、年齢と返中左の2つのサブテストを除いて−0.16〜−0.34と有意であった(脳機能検査で用いた中ペグの返し動作では、相関係数は−0.20と有意な負の相関係数を示した)。認知症者においては、巧緻動作能力と認知機能との負の関係が示唆された。  HDS-R and age / IPUT subtest correlation coefficients for people with dementia were negatively correlated and were significant between -0.16 and -0.34 except for the two subtests on the left in age and return (In the return movement of the medium peg used in the brain function test, the correlation coefficient was -0.20, showing a significant negative correlation coefficient). In people with dementia, a negative relationship between skillful movement ability and cognitive function was suggested.

[脳機能検査の年代別基準値の作成]
表3は、脳機能検査基準値作成のための被検者属性と人数を表したものである。基準値は、身体的・認知的に問題なく日常生活を行っている方5歳〜94歳まで1607名にIPUTの6サブテストについて両手各2回ずつ計12動作を実施し作成した。
[Creation of age-specific reference values for brain function tests]
Table 3 shows the subject attributes and the number of persons for creating a brain function test reference value. The reference value was created by performing a total of 12 movements twice for each of both hands for 6 subtests of the IPUT for 1607 people aged 5 to 94 years who have daily life without physical or cognitive problems.

Figure 2013078552
Figure 2013078552

表3の1607名のIPUTの6サブテストについて両手各2回ずつ計12動作の平均値、および20歳から94歳の健常者563名に対して実施したHDS−R平均値を棒グラフにしたものが図1である。  A bar graph of the average value of 12 movements for each of the 2 sub-hands of 1607 IPUT subtests in Table 3 and the average value of HDS-R performed on 563 healthy subjects aged 20 to 94 years Is FIG.

Figure 2013078552
Figure 2013078552

IPUTの6つのサブテストは左右の手で同様に、5歳より巧緻動作機能が向上し、ほぼ15〜24歳から55〜64歳歳までピークになり、その後加齢により巧緻動作機能が低下するUカーブを描いた。反面、認知機能の指標としたHDS−Rでは20歳代から50〜54歳代まではほぼ変化がないが、55歳以後加齢と共に徐々に低下することが示された。このことは、55歳以後加齢と共に巧緻動作機能・認知機能が低下することを示した。  The IPUT's six subtests, with left and right hands, improved skillful movement function from 5 years old, peaked from about 15-24 years old to 55-64 years old, and then skillful movement function declined by aging I drew a U curve. On the other hand, HDS-R, which is an index of cognitive function, showed almost no change from the 20s to the 50s to 54s, but gradually decreased with age after the 55s. This showed that skillful movement function and cognitive function decreased with aging after 55 years old.

これらの結果から、巧緻動作能力が認知機能を反映する脳機能の指標として用いることが可能であると考えられる。また、IPUTの12のサブテストがほぼ同様の結果を示した。認知機能を反映する脳機能検査としてはPUTの12のサブテストの一つをすることで示されることが考えられる。
脳機能検査を実施する高齢者は、白内障などの視覚障害を有することの多い。そのため、視覚の影響を多く受ける移し動作ではなく返し動作を脳機能検査とした。使用するペグは、視覚障害を揺する高齢者に見にくい小ペグや持ち運びには大きすぎる大ペグではなく、持ち運びやすく高齢者にも扱いやすい大きさの中ペグを用いた。また、学習したものが失われてゆく認知症患者では、これまでの研究において非利き手に比べ、利き手の巧緻動作と認知機能の高い関係が示されている。これらのことより、脳機能検査では中ペグ移し動作を利き手で行うこととした。
From these results, it is considered that skillful movement ability can be used as an index of brain function reflecting cognitive function. The 12 subtests of IPUT showed almost the same result. It is conceivable that the brain function test reflecting the cognitive function is shown by performing one of the 12 subtests of the PUT.
Older people who perform brain function tests often have visual impairments such as cataracts. For this reason, the brain function test was performed with the return motion, not the transfer motion, which has a large visual influence. The pegs used were not small pegs that are difficult to see for elderly people who are visually impaired or large pegs that are too large to carry, but medium pegs that are easy to carry and handle for elderly people. In addition, in patients with dementia who lose what they have learned, previous studies have shown that there is a higher relationship between the dexterous movement of the dominant hand and cognitive function than the non-dominant hand. For these reasons, we decided to move the middle peg with a dominant hand in the brain function test.

表4は、1607名の健常者におけるIPUTの中ペグの返し動作の結果(表3)を用いた脳機能検査の健常者平均値と認知症患者の172名におけるIPUTの中ペグの返し動作の結果(表2)を用いた脳機能検査の認知症者平均値である。認知症者平均値は、70歳以下の認知症者の平均値・SD(標準偏差)は、70−74歳の平均値・SD(標準偏差)を基にした。健康な人100人の内68人が入る範囲、統計的に言えば平均値±SD(標準偏差)の範囲(全測定者の68.3%を含む)を健常者基準範囲、認知症患者100人の内68人が入る範囲を認知症者基準範囲とした。健常者基準範囲の最低値となる平均値+SDまでを「正常レベル」、認知症者基準範囲の最高値となる平均値−SD以下を「危険レベル」、「正常レベル」と「危険レベル」の間を「注意レベル」とし各年代で算出した。
健常者・認知症者の平均値を基準値とし、認知症者の基準値を危険値とし健常者基準値に対する認知症者基準値の割合(健常者の基準値×100÷認知症者の基準値)を危険率として示したものである。
Table 4 shows the average value of brain function tests using the results of the return operation of the middle peg of IPUT in 1607 healthy subjects (Table 3) and the return operation of the middle peg of IPUT in 172 patients with dementia It is a dementia average value of a brain function test using a result (Table 2). The average value of dementia was based on the average value / SD (standard deviation) of 70-74 years old. The range that 68 out of 100 healthy people enter, statistically speaking, the range of mean ± SD (standard deviation) (including 68.3% of all measurers) is the standard range for healthy subjects, 100 patients with dementia The range that 68 of the people can enter was defined as the dementia standard range. “Normal level” up to the average value + SD that is the lowest value of the healthy person reference range, “Danger level”, “Normal level” and “Danger level” that are below the average value −SD that is the highest value of the dementia reference range The interval was taken as the “attention level” and calculated for each age.
The average value of healthy / demented persons is the reference value, the reference value of the demented person is the risk value, and the ratio of the dementia reference value to the healthy person reference value (the reference value of the healthy person × 100 ÷ the standard of the demented person Value) as a risk factor.

Figure 2013078552
Figure 2013078552

各年代の「正常レベル」は、おおよそ90%以上であり、「危険レベル」は60%から90%以下と年齢と共に割合があがっている。また、「注意レベル」はそれに伴い、若い年齢ほど幅が広く高齢になるほど範囲が少なくなっている。  The “normal level” of each age is approximately 90% or more, and the “risk level” is 60% to 90% or less, and the ratio increases with age. In addition, the “attention level” is broader as the age is younger and the range decreases as the age increases.

この基準値を基に下記の数式1に当てはめて、同年代健常者の脳機能に対する被検者の脳機能を%で示すことが可能となる。なお、数式1を用いるのは、サブテストが60秒以内に完了した場合である。  Based on this reference value, it can be applied to the following formula 1, and the brain function of the subject with respect to the brain function of the healthy person of the same age can be expressed in%. Note that Equation 1 is used when the subtest is completed within 60 seconds.

[数式1] 100×基準値(秒)÷測定値(秒)    [Formula 1] 100 × reference value (second) ÷ measured value (second)

60秒間の規定の時間に完了できなかった場合は、60秒間に実施できたペグの本数により、表5を用いて脳機能を判定する。表5は、同年代健常者の脳機能に対する被検者の脳機能を%で表している。各値は下記の数式2に基づいて算出されている。  If it cannot be completed within the prescribed time of 60 seconds, the brain function is determined using Table 5 based on the number of pegs that could be implemented in 60 seconds. Table 5 shows the brain function of the subject with respect to the brain function of healthy subjects of the same age in%. Each value is calculated based on Equation 2 below.

Figure 2013078552
Figure 2013078552

[数式2] 100×基準値÷(540÷〔60秒以内に実施したペグ本数〕)    [Formula 2] 100 × reference value ÷ (540 ÷ [number of pegs implemented within 60 seconds])

図2は、脳機能検査の過程を示した流れ図である。検査システムを作動し画面の指示に従って、年齢、性別を入力する。次に、脳機能検査装置の画面の指示に従い、脳機能検査は9本のペグの返し動作操作を60秒間で行う。60秒以内で可能であった場合は、実施した時間(秒数)を、60秒間で9本のペグ操作が実施できなかった場合は、実施できたペグ数が測定される。
次に、被検者情報である年齢を入力する。既存被検者と被検者情報を入力した新規被検者は9本のペグの返し動作を計測する(処理1)。測定値データの編集を行う場合は処理2に移る。また、結果を表示する場合は処理3に移る。
FIG. 2 is a flowchart showing the process of the brain function test. Activate the inspection system and follow the instructions on the screen to enter your age and gender. Next, according to the instructions on the screen of the brain function test apparatus, the brain function test performs the return operation of nine pegs in 60 seconds. If it was possible within 60 seconds, the implemented time (seconds) is measured. If nine peg operations could not be performed in 60 seconds, the number of pegs that could be implemented was measured.
Next, the age which is subject information is input. The new subject who has entered the existing subject and subject information measures the return motion of the nine pegs (Process 1). When editing the measured value data, the process proceeds to process 2. If the result is to be displayed, the process proceeds to process 3.

図3は、手指巧緻動作能力検査システムの内、新規計測の過程を示した流れ図である。新規計測を行う時、画面上の指示に従って行う場合と独自に手入力する方法に分かれる。画面上の指示に従う場合、練習動作を行う。次に、練習動作ができた場合測定を開始する。
脳機能検査は9本のペグ操作を60秒間で行う。60秒以内で可能であった場合は、実施した時間(秒数)を、60秒間で9本のペグ操作が実施できなかった場合は、実施できたペグ数を入力する。
計測日とあらかじめ入力されている被験者の生年月日より計測時の年齢を自動的に計算する。
画面上の指示に従って行う場合と独自に手入力するどちらの場合も同年代健常者を対象に求めた基準値を比較して、同年代健常者の基準値を基に脳機能を算出する結果と、同年代健常者の基準値を基にした脳機能が100%を下回る場合は、同年代認知症者の基準値を危険値とし同年代健常者基準値に対する危険率「認知症者基準値の割合(健常者の基準値×100÷認知症者の基準値)」を算出する結果の保存を行う。また、危険率について「正常レベル」、「注意レベル」、「危険レベル」の判別ともに、それぞれの結果の意味を画面上で表示する。
FIG. 3 is a flowchart showing a new measurement process in the finger skillful movement ability inspection system. When performing a new measurement, it is divided into the case of following the instructions on the screen and the method of manual input independently. Follow the on-screen instructions and practice. Next, when the practice operation is completed, the measurement is started.
The brain function test involves nine peg operations in 60 seconds. If it was possible within 60 seconds, enter the implemented time (in seconds), and if 9 peg operations could not be implemented in 60 seconds, enter the number of pegs that could be implemented.
The age at the time of measurement is automatically calculated from the date of measurement and the date of birth of the subject entered in advance.
In both cases of following the instructions on the screen and manually entering manually, the reference values obtained for healthy subjects of the same age are compared, and the brain function is calculated based on the reference values of healthy people of the same age. If the brain function based on the reference value for healthy subjects is less than 100%, the reference value for people with dementia of the same age is taken as the risk value, and the ratio of the risk value to the reference value for healthy people of the same age The result of calculating “reference value × 100 ÷ reference value of persons with dementia” ”is stored. In addition, regarding the risk factor, the “normal level”, “caution level”, and “danger level” are discriminated and the meaning of each result is displayed on the screen.

図4は、脳機能検査システムの内、データの編集の過程を示した流れ図である。脳機能検査システムの画面に従い、被検者の過去のデータを呼び出し、脳機能検査を実施し60秒間で9本のペグ操作が実施出来た場合はその測定時間(秒)を、60秒間で9本のペグ操作が実施出来なかった場合は実施できた本数が自動的に入力される。同年代健常者を対象に求めた基準値を比較して、同年代健常者の基準値を基に脳機能を算出する結果と、同年代健常者の基準値を基にした脳機能が100%を下回る場合は、同年代認知症者の基準値を危険値とし同年代健常者基準値に対する危険率「認知症者基準値の割合(健常者の基準値×100÷認知症者の基準値)」を算出する結果の保存を行う。また、危険率について「正常レベル」、「注意レベル」、「危険レベル」の判別ともに、それぞれの結果の意味を画面上で表示する。  FIG. 4 is a flowchart showing a data editing process in the brain function testing system. In accordance with the screen of the brain function test system, the past data of the subject is called, and when the brain function test is performed and nine peg operations can be performed in 60 seconds, the measurement time (seconds) is 9 in 60 seconds. If the peg operation of the book could not be performed, the number that could be implemented is automatically input. When the brain function based on the reference value of the healthy person of the same age and the result of calculating the brain function based on the reference value of the healthy person of the same age and the brain function based on the reference value of the healthy person of the same age are less than 100% Is the result of calculating the risk ratio “percentage of dementia standard value (standard value of healthy person × 100 ÷ standard value of dementia)” relative to the standard value of healthy people of the same age, taking the standard value of people with dementia of the same age as the risk value Save the file. In addition, regarding the risk factor, the “normal level”, “caution level”, and “danger level” are discriminated and the meaning of each result is displayed on the screen.

図5は、手指巧緻動作能力検査システムの内、結果表示の過程を示した流れ図である。処理1(新規計測の過程)もしくは処理2(データの編集の過程)で保存された結果を基に、測定結果の抽出・選択、結果の評価、測定結果及び評価結果の表示を行う。  FIG. 5 is a flowchart showing a result display process in the finger skillful movement capability inspection system. Based on the results stored in process 1 (new measurement process) or process 2 (data editing process), measurement results are extracted and selected, results are evaluated, and measurement results and evaluation results are displayed.

図6は、本システムのブロック図である。脳機能検査システムでは、被検者選択手段101において、検査実施が初めての場合と2回目以降の場合の選択を行う。初回の場合は、被検者情報入力手段102において被検者情報を入力する。新規検査者及び2回目以降の検査者共に新規計測データ入力手段103において左右の手それぞれで6つのサブテストの中から必要な検査を選んで実施した結果を入力する。新規及び既存データの修正は、既存データ編集手段104において実施する。これら新規計測データ入力手段103及び既存データ編集手段104を経たデータは、演算手段106にて健常者の能力との比較(能力算出)が行われ、結果はメモリ107に保存される。演算手段106及びメモリ107からの情報は結果表示手段105において、同年代健常者の基準値を基にした脳機能が100%を下回る場合は、同年代認知症者の基準値を危険値とし同年代健常者基準値に対する危険率「認知症者基準値の割合(健常者の基準値×100÷認知症者の基準値)」を算出する結果の保存を行う。また、危険率について「正常レベル」、「注意レベル」、「危険レベル」の判別ともに、それぞれの結果の意味を画面上で表示される。  FIG. 6 is a block diagram of this system. In the brain function test system, the subject selection means 101 performs selection for the first test execution and for the second and subsequent tests. In the first case, the subject information is input by the subject information input means 102. Both the new inspector and the second and subsequent inspectors use the left and right hands in the new measurement data input means 103 to select necessary tests from the six subtests and input the results. Correction of new and existing data is performed in the existing data editing means 104. The data that has passed through the new measurement data input means 103 and the existing data editing means 104 is compared with the ability of the normal person (ability calculation) by the calculation means 106, and the result is stored in the memory 107. When the brain function based on the reference value of the same age healthy person is less than 100% in the result display means 105 in the result display means 105, the information from the calculation means 106 and the memory 107 is taken as the risk value as the reference value of the same age demented person. The result of calculating the risk rate “the ratio of the dementia standard value (normal standard value × 100 ÷ dementia standard value)” with respect to the standard value is stored. In addition, regarding the risk factor, the meaning of each result is displayed on the screen together with the discrimination of “normal level”, “caution level”, and “danger level”.

Claims (4)

被検者の手指巧緻動作能力を検査するシステムであって、両端部の色が異なる9本のペグと、当該ペグが着脱可能であって、縦に3個ずつ3列に9個の孔が縦横等間隔に配列するボードとを用い、1本ずつ抜いたのち、上下を逆にして差し込む返し動作の時間を計測し、計測値を入力する計測値入力手段と、前記計測値と、予め健常者を対象に求めた基準値を比較して、同年代健常者の基準値を基に脳機能を算出するステップと、同年代認知症者の基準値を危険値とし同年代健常者基準値に対する危険率「認知症者基準値の割合(健常者の基準値×100÷認知症者の基準値)」を算出する能力算出手段を備えることを特徴とするシステム。  A system for inspecting the finger's skillful movement ability of a subject, wherein nine pegs having different colors at both ends and the pegs are detachable, and three holes are arranged vertically in three rows of nine holes. Using a board arranged at equal intervals in the vertical and horizontal directions, after pulling out one by one, measuring the time of return operation to insert upside down, measuring value input means for inputting the measured value, the measured value, previously healthy Comparing the reference values obtained for the elderly, calculating the brain function based on the reference values of healthy people of the same age, and the risk factor for the normal values of healthy people of the same age with the reference value of the same age dementia as the risk value A system comprising ability calculating means for calculating a ratio of a dementia standard value (standard value of healthy person × 100 ÷ standard value of dementia). コンピュータを用いて構築された被検者の手指巧緻動作能力を検査する方法であって、前記コンピュータが備える計測値入力手段が、両端部の色が異なる9本のペグと、当該ペグが着脱可能であって、縦に3個ずつ3列に9個の孔が縦横等間隔に配列するボードとを用い、1本ずつ抜いたのち、上下を逆にして差し込む返し動作の時間を計測し、計測値を入力するステップと、次いで、前記コンピュータが備える能力算出手段が、前記計測値と、予め健常者を対象に求めた基準値とを比較して、同年代健常者の基準値を基に脳機能を算出するステップと、同年代認知症者の基準値を危険値とし同年代健常者基準値に対する危険率「認知症者基準値の割合(健常者の基準値×100÷認知症者の基準値)」を算出することを実行することを特徴とする方法。  A method for inspecting the finger skillful movement ability of a subject constructed using a computer, wherein the computer is equipped with nine measurement values input means with different colors at both ends, and the pegs are detachable Then, using a board with 9 holes arranged in 3 rows vertically and 9 rows arranged in equal intervals vertically and horizontally, after pulling out one by one, measure the time of return operation to insert upside down and measure A step of inputting a value, and then the ability calculation means provided in the computer compares the measured value with a reference value obtained in advance for a healthy person, and based on the reference value of a healthy person of the same age, And calculating the risk rate for the same-aged healthy person standard value as a risk value, “Ratio of dementia standard value (standard value for healthy person × 100 ÷ standard value for people with dementia)” It is characterized by performing the calculation how to. 被検者の脳機能を検査する方法であって、両端部の色が異なる9本のペグと、当該ペグが着脱可能であって、縦に3個ずつ3列に9個の孔が縦横等間隔に配列するボードとを用い、1本ずつ抜いたのち、上下を逆にして差し込む返し動作の時間を計測し、計測値を求める工程と、次いで、前記計測値と、予め健常者を対象に求めた基準値を比較して、同年代健常者の基準値を基に脳機能を算出するステップと、同年代認知症者の基準値を危険値とし同年代健常者基準値に対する危険率「認知症者基準値の割合(健常者の基準値×100÷認知症者の基準値)」を算出する工程を含むことを特徴とする方法。  A method for examining a brain function of a subject, wherein nine pegs having different colors at both ends and the pegs are detachable, and nine holes are arranged in three rows vertically and horizontally. Using a board arranged at intervals, after pulling out one by one, measuring the time of return operation to insert upside down, obtaining the measurement value, then, the measurement value and the healthy subject in advance Comparing the obtained reference values, calculating the brain function based on the reference values of healthy people of the same age, and using the reference value of people with the same age as dementia as the risk value, A method comprising a step of calculating a ratio of values (reference value of healthy person × 100 ÷ reference value of person with dementia) ”. コンピュータを、被検者の手指巧緻動作能力を検査する手段として機能させるためのプログラムであって、前記コンピュータを、両端部の色が異なる9本のペグと、当該ペグが着脱可能であって、縦に3個ずつ3列に9個の孔が縦横等間隔に配列するボードとを用い、1本ずつ抜いたのち、上下を逆にして差し込む返し動作の時間を計測し、計測値を入力する計測値入力手段として機能させ、次いで、前記コンピュータを、前記計測値と、予め健常者を対象に求めた基準値とを比較して、同年代健常者の基準値を基に脳機能を算出するステップと、同年代認知症者の基準値を危険値とし同年代健常者基準値に対する危険率「認知症者基準値の割合(健常者の基準値×100÷認知症者の基準値)」を算出する能力算出手段として機能させることを特徴とするプログラム。  A program for causing a computer to function as a means for inspecting the hand skillful movement ability of a subject, wherein the computer includes nine pegs having different colors at both ends, and the pegs are detachable, Using a board with 9 holes arranged in 3 rows vertically and 9 holes arranged at equal intervals in the vertical and horizontal direction, after pulling out one by one, measure the time for the return operation to insert upside down and input the measured value A step of calculating a brain function based on a reference value of a healthy person of the same age by causing the computer to function as a measurement value input means and then comparing the measurement value with a reference value obtained in advance for a healthy person And the ability to calculate the risk ratio “percentage of dementia standard value (standard value of healthy person × 100 ÷ reference value of dementia)” relative to the standard value of healthy people of the same age, taking the standard value of people with dementia of the same age as the risk value To function as a calculation means A program characterized by
JP2011232244A 2011-10-04 2011-10-04 System, method and program for examining brain function Pending JP2013078552A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011232244A JP2013078552A (en) 2011-10-04 2011-10-04 System, method and program for examining brain function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011232244A JP2013078552A (en) 2011-10-04 2011-10-04 System, method and program for examining brain function

Publications (1)

Publication Number Publication Date
JP2013078552A true JP2013078552A (en) 2013-05-02

Family

ID=48525458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011232244A Pending JP2013078552A (en) 2011-10-04 2011-10-04 System, method and program for examining brain function

Country Status (1)

Country Link
JP (1) JP2013078552A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6340465B1 (en) * 2017-09-29 2018-06-06 茨城県 System for testing cognitive impairment
JP2019075071A (en) * 2017-10-13 2019-05-16 株式会社Splink Insurance fee calculation system, insurance fee calculation method, and program
CN113055746A (en) * 2021-04-19 2021-06-29 广州欢网科技有限责任公司 Old people monitoring method, device, server and system based on television watching behaviors

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6340465B1 (en) * 2017-09-29 2018-06-06 茨城県 System for testing cognitive impairment
JP2019063084A (en) * 2017-09-29 2019-04-25 茨城県 System for examining cognitive dysfunction
JP2019075071A (en) * 2017-10-13 2019-05-16 株式会社Splink Insurance fee calculation system, insurance fee calculation method, and program
JP7036374B2 (en) 2017-10-13 2022-03-15 株式会社Splink Insurance premium calculation system and insurance premium calculation method
CN113055746A (en) * 2021-04-19 2021-06-29 广州欢网科技有限责任公司 Old people monitoring method, device, server and system based on television watching behaviors

Similar Documents

Publication Publication Date Title
Prentašić et al. Diabetic retinopathy image database (DRiDB): a new database for diabetic retinopathy screening programs research
Gopalakrishna et al. Applying Grading of Recommendations Assessment, Development and Evaluation (GRADE) to diagnostic tests was challenging but doable
Hernández et al. Brain white matter damage in aging and cognitive ability in youth and older age
JP6973802B2 (en) Cognitive function evaluation system
Diaz et al. Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease
Chapman et al. Brain ERP components predict which individuals progress to Alzheimer's disease and which do not
Cabrera DeBuc et al. Investigating multimodal diagnostic eye biomarkers of cognitive impairment by measuring vascular and neurogenic changes in the retina
Fyffe et al. Explaining differences in episodic memory performance among older African Americans and whites: the roles of factors related to cognitive reserve and test bias
Dong et al. Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study
Chen et al. Analysis of autofluorescent retinal images and measurement of atrophic lesion growth in Stargardt disease
Deal et al. Retinal signs and risk of incident dementia in the Atherosclerosis Risk in Communities study
Moorhouse et al. Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study
Tippett et al. Compromised visually guided motor control in individuals with Alzheimer’s disease: Can reliable distinctions be observed?
Lenhart et al. The role of magnetic resonance imaging in diagnosing optic nerve hypoplasia
van der Stelt et al. Intellectual awareness of naming abilities in people with chronic post-stroke aphasia
Wang et al. Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes
Rufai et al. Detection of intracranial hypertension in children using optical coherence tomography: a systematic review
JP2013078552A (en) System, method and program for examining brain function
Antony Measures for specific phobia
Myung et al. Evaluation of vascular disease progression in retinopathy of prematurity using static and dynamic retinal images
Frampton et al. Accuracy of fundus autofluorescence imaging for the diagnosis and monitoring of retinal conditions: a systematic review
Gijsbertse et al. Computer-aided detection of fasciculations and other movements in muscle with ultrasound: Development and clinical application
Ahmad Fadzil et al. Analysis of foveal avascular zone for grading of diabetic retinopathy
JP6207547B2 (en) Method, system and program for determining the degree of dementia
Chen et al. A pilot study for reliability and validity of mini-physical performance test for Chinese male elders